The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
Learn about the strategies that have been successful at Dignity Health in developing a purchased services product line. In this webinar we explain…
Webcast
in this short video webcast, Mike Schiller, Senior Director, AHRMM and Dennis Othman, Senior Director, SMI discuss the four key pillars of knowledg
Podcasts
In this three-part webcast, Howard Mann, Vice President, Supply Chain Management at Cardiovascular Care Group discusses the basics and relationship
On-Demand Educational Webinars
This webinar gives a brief overview of the ISM Report On Business, one of the most reliable near-term economic barometers available, and explains why…
Podcasts
A thought-leader panel discussion about the role of GPOs within the changing healthcare landscape and the and the daily decision of using a GPO or
On-Demand Educational Webinars
This webinar explains how supplier diversity can be a valuable investment toward sustainability. Presenters define supplier diversity and the…